Novo Nordisk AS (NOVO B) - Medical Equipment - Deals and Alliances Profile

Date: July 21, 2016
Pages: 61
Price:
US$ 250.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: N17FE363F21EN
Leaflet:

Download PDF Leaflet

Novo Nordisk AS (NOVO B) - Medical Equipment - Deals and Alliances Profile
Summary

Novo Nordisk A/S (Novo Nordisk) is a healthcare company that discovers, develops and manufactures innovative biological medicines. It focuses at developing drugs for treating diabetes and other serious chronic conditions including hemophilia, growth disorders and obesity. The company’s product portfolio includes new-generation insulins, modern insulins, human insulins, oral antidiabetic agents, diabetes devices and others. Novo Nordisk also offers biopharmaceuticals for treating haemostasis, human growth hormone products and hormone replacement therapy. With subsidiaries in Europe, North America, Asia, Latin America and Australia, it markets its products in several countries around the world. It is a subsidiary of Novo A/S. Novo Nordisk is headquartered in Bagsvaerd, Denmark.

Novo Nordisk AS (NOVO B) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope
  • Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
  • Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
  • Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
  • Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
  • Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
  • Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
  • Business Description - A brief description of the company's operations.
  • Key Employees - A list of the key executives of the company.
  • Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
  • Key Competitors - A list of the key competitors of the company.
  • Key Recent Developments - A brief on recent news about the company.
Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
  • The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion/divestiture strategy
  • The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
  • Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
  • The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
  • Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
  • Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company.
Novo Nordisk A/S, Medical Equipment, Deals By Year, 2010 to YTD 2016
Novo Nordisk A/S, Medical Equipment Deals By Type, 2010 to YTD 2016
Novo Nordisk A/S, Medical Equipment, Deals By Region, 2010 to YTD 2016
Novo Nordisk A/S, Medical Equipment, Deals By Market, 2010 to YTD 2016
Novo Nordisk A/S, Medical Equipment, Deals Summary, 2010 to YTD 2016
Novo Nordisk A/S, Medical Equipment, Deal Details
Venture Financing
Ra Pharma Raises USD58.5 Million in Series B Financing
Cianna Medical Raises USD4 Million in Venture Financing Round
HTG Molecular Diagnostics Raises Funds Through Extended Series E Financing
Nevro Raises US$48 Million In Series C Financing
Ceterix Orthopaedics Raises US$19.5 Million In Series B Financing
Cianna Medical Secures US$12 Million In Series B Financing
Partnerships
Novo Nordisk Enters into Agreement with IBM Watson Health
Novo Nordisk Enters into Research Agreement with Massachusetts Institute of Technology
BioClinica Enters Into Agreement With NNIT For Clinical Trial Management System
Novo Nordisk Enters Into Co-Development Agreement With Oxford University
Zosano Pharma Terminates Licensing Agreement with Novo Nordisk
Equity Offering
NNIT Prices IPO for USD191 Million
Novo Nordisk A/S - Key Competitors
Key Employees
Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Strategy And Business Planning
Dec 10, 2015: Novo Nordisk and IBM partner to build diabetes care solutions on the Watson Health Cloud
May 04, 2015: Novo Nordisk invests DKK 1.5 billion in new haemophilia treatment manufacturing facility in Denmark
Apr 10, 2015: Novo Nordisk opens new insulin formulation and filling facility in Russia
Financial Announcements
Apr 29, 2016: Novo Nordisk increased adjusted operating profit by 10% in local currencies in the first quarter of 2016
Feb 03, 2016: Novo Nordisk increased operating profit by 43% in 2015 to DKK 49.4 billion
Aug 06, 2015: Novo Nordisk increased operating profit in Danish kroner by 57% in the first six months of 2015 to DKK 26.3 billion
Apr 30, 2015: Novo Nordisk: Increased operating profit in Danish kroner by 73% in the first quarter of 2015 to DKK 13.9 billion
Jan 30, 2015: Novo Nordisk increased operating profit in local currencies by 13% in 2014
Corporate Communications
Feb 12, 2016: Proposed changes in composition of the Board of Directors of Novo Nordisk
Jan 27, 2015: TransCelerate BioPharma Welcomes Merck & Co. and Novo Nordisk to its Membership Roster
Product News
Jul 16, 2015: Novo Nordisk Receives FDA Approval for FlexPro PenMate for People with Growth Hormone-Related Disorders
Product Approvals
Jul 16, 2015: Novo Nordisk Receives FDA Approval for FlexPro PenMate for People with Growth Hormone-Related Disorders
Other Significant Developments
Jul 04, 2016: Novo Nordisk invests DKK 400 million in an expanded production plant in Kalundborg
Nov 24, 2015: All Novo Nordisk production plants to run on renewable power in 2020
Nov 18, 2015: Highlights to be presented at Novo Nordisk's Capital Markets Day 2015
Oct 01, 2015: Xybion announces that Novo Nordisk selects Pristima to manage pharmacology research studies across all research sites
Sep 29, 2015: Novo Nordisk Launches New Medical Resource for People Living with Hemophilia and Other Rare Bleeding Disorders
Aug 26, 2015: Novo Nordisk plans 2 billion US dollar investment in new production facilities in Clayton, North Carolina and Malov, Denmark
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Novo Nordisk A/S, Medical Equipment, Key Facts, 2015
Novo Nordisk A/S, Medical Equipment, Deals Summary, 2010 to YTD 2016
Novo Nordisk A/S, Medical Equipment, Deals By Year, 2010 to YTD 2016
Novo Nordisk A/S, Medical Equipment Deals By Type, 2010 to YTD 2016
Novo Nordisk A/S, Medical Equipment, Deals By Region, 2010 to YTD 2016
Novo Nordisk A/S, Deals By Market, 2010 to YTD 2016
Novo Nordisk A/S, Medical Equipment, Deals Summary, 2010 to YTD 2016
Ra Pharma Raises USD58.5 Million in Series B Financing
Cianna Medical Raises USD4 Million in Venture Financing Round
HTG Molecular Diagnostics Raises Funds Through Extended Series E Financing
Nevro Raises US$48 Million In Series C Financing
Ceterix Orthopaedics Raises US$19.5 Million In Series B Financing
Cianna Medical Secures US$12 Million In Series B Financing
Novo Nordisk Enters into Agreement with IBM Watson Health
Novo Nordisk Enters into Research Agreement with Massachusetts Institute of Technology
BioClinica Enters Into Agreement With NNIT For Clinical Trial Management System
Novo Nordisk Enters Into Co-Development Agreement With Oxford University
Zosano Pharma Terminates Licensing Agreement with Novo Nordisk
NNIT Prices IPO for USD191 Million
Novo Nordisk A/S, Key Competitors
Novo Nordisk A/S, Key Employees
Novo Nordisk A/S, Subsidiaries

LIST OF FIGURES

Novo Nordisk A/S, Medical Equipment, Deals by Type, 2010 to YTD 2016
Novo Nordisk A/S, Medical Equipment, Deals By Year, 2010 to YTD 2016
Novo Nordisk A/S, Medical Equipment, Deals By Region, 2010 to YTD 2016
Novo Nordisk A/S, Medical Equipment, Deals By Market, 2010 to YTD 2016
Novo Nordisk A/S, Medical Equipment, Deals By Year, 2010 to YTD 2016
Novo Nordisk A/S, Medical Equipment, Deals by Type, 2010 to YTD 2016
Novo Nordisk A/S, Medical Equipment, Deals By Region, 2010 to YTD 2016
Novo Nordisk A/S, Medical Equipment, Deals by Market, 2010 to YTD 2016
Skip to top


Ask Your Question

Novo Nordisk AS (NOVO B) - Medical Equipment - Deals and Alliances Profile
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: